July 08, 2013
Off
Latest FDA approval of Alzheimer’s patch from Novartis gives patients some relief
The Exelon Patch from Novartis recently received FDA approval as a high-dose medication for patients with late stage Alzheimer’s disease. Medical experts say the patch is easier to take than capsules, providing a small but necessary boost to Alzheimer’s sufferers.
Hopefully we will see more early stage drugs approved.
